CHIPS Biobank, Canada

Registration Status: Pending

Objective: For those participants that consented to biobank, their de-identified samples will continue to be stored in the biobank until 31st December 2038 for future research purposes. The only time any personally identifiable information will be used is in the data analyses and linking the personal data to the biological data. This is necessary to understand relationships between age, sex, and gender on diabetes. However, all personal data will be kept in files that are only labeled with the subject ID number. This way, participants can withdraw their samples from the biobank at any time and their samples would be destroyed.

Registered Biobank Name	CHIPS Biobank
Biobank Leader	Gemma Anderson
Country	Canada
Email for biobank inquiries	gemma.anderson@cw.bc.ca
Principal Investigator	Constadina Panagiotopoulos
Website
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper

Biospecimen Collected:

Cohort Highlights

100 cases Next Generation Sequencing assay to detect all classes of genetic variant in Lung Cancer using a single Diagnostic test.
200 cases Colorectal TMA for QC purposes in support of study of tumor infiltrating lymphocytes in ovarian cancer tissues.
Build 300 cases breast cancer TMA containing primary tumour and matched metastatic LN for various subtypes (luminal, HER2, Triple negative). Start with Triple negatives.
125 cases Breast tumour and metastatic lymph nodes in breast cancer cases with outcomes of metastasis to lung or bone.
100 cases of rare tumours - fibrolamellar hepatocellular carcinoma. FFPE, frozen, BC.
200 cases of FFPE tissue sections from breast, lung adenocarcinoma, and lung squamous cell carcinoma with matching normal tissue (only pathology data requested).